That report is incredibly confused in its discussion of competitors to 68GA-PSMA11 (Illucix)
In their consideration of the comparison of 68GA-PSMA11 to 18F-DCFPyL they conclude they are about the same in terms of diagnostic value but they then go on to cite a paper that compared 68Ga-PSMA to 18F-Fluciclovine that reached the conclusion that 68Ga-PSMA was superior.
The problem is that 18F-Fluciclovine is an older class of tracer nothing like 18F-DCFPyL and is no way a serious competitor to Illucix. To make the report harder to read they don't refer to 18F-Fluciclovine by name instead they just call it 18F PET CT which is a fairly meaningless term which could confusingly also include 18F-DCFPyL.
I can't decide if they were simply out of their depth or were deliberately trying to downplay competition.
That report is incredibly confused in its discussion of...
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.32 |
Change
0.100(0.52%) |
Mkt cap ! $6.465B | |||
| Open | High | Low | Value | Volume |
| $19.30 | $19.50 | $19.08 | $22.36M | 1.160M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3890 | $19.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.34 | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| TLX (ASX) Chart |